Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial

2017-06-292026-03-272017-06-292014María Guadalupe Camal Ibáñez1398-564710.1111/bdi.12196https://doi.org/10.1111/bdi.12196https://repositorio.inprf.gob.mx/handle/123456789/4662engacceso cerradoMelatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trialartículo1399-56184Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz410-421Dinamarca16Bipolar DisorderBlood PressureFat MassMelatoninMetabolicSchizophreniaSecond-Generation AntipsychoticWeight